Loading
NEU-002 is an experimental enzyme therapy: elastase for intravenous delivery from Onchilles Pharma, in preclinical development for solid tumours.
NEU-002 is an enzyme therapy: elastase for intravenous delivery from Onchilles Pharma. The intravenous counterpart of N17350, built on the same ELANE-pathway approach and designed to eliminate tumours while mobilising an adaptive immune response. Its furthest stage is preclinical development, for solid tumours (not specified). No clinical trial naming it is registered on ClinicalTrials.gov. Company: 'continues through preclinical development'. No registered trial. It has not been shown to work in people.
The intravenous counterpart of N17350, built on the same ELANE-pathway approach and designed to eliminate tumours while mobilising an adaptive immune response.
1.NEU-002 binds its target.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"NEU-002" OR ABSTRACT:"NEU-002") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about NEU-002, not a curated reading list.
Shares Onchilles Pharma, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/